ALNYLAM PHARMACEUTICALS, INC. Increase (Decrease) in Accounts Payable
ALNYLAM PHARMACEUTICALS, INC. (ALNY) reported Increase (Decrease) in Accounts Payable of -$3.72 million for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-10-31.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2019-10-31
- ALNYLAM PHARMACEUTICALS, INC. increase (decrease) in accounts payable for the quarter ending 2019-09-30 was -$30.09M, a 431.18% decline year-over-year.
- ALNYLAM PHARMACEUTICALS, INC. increase (decrease) in accounts payable for the quarter ending 2019-06-30 was $43.50M.
- ALNYLAM PHARMACEUTICALS, INC. increase (decrease) in accounts payable for the quarter ending 2019-03-31 was -$17.13M.
- ALNYLAM PHARMACEUTICALS, INC. increase (decrease) in accounts payable for the quarter ending 2018-12-31 was $16.13M, a 30.78% increase year-over-year.
- ALNYLAM PHARMACEUTICALS, INC. increase (decrease) in accounts payable for fiscal 2018 was $15.48M.
- ALNYLAM PHARMACEUTICALS, INC. increase (decrease) in accounts payable for fiscal 2017 was -$4.94M, a 148.91% decline from fiscal 2016.
- ALNYLAM PHARMACEUTICALS, INC. increase (decrease) in accounts payable for fiscal 2016 was $10.10M, a 502.51% increase from fiscal 2015.
- ALNYLAM PHARMACEUTICALS, INC. increase (decrease) in accounts payable for fiscal 2015 was $1.68M, a 81.04% decline from fiscal 2014.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2019-09-30 | -$30.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $13.41M derived: sum of 2 quarters · filed 2019-10-31 | -$3.72M 10-Q · filed 2019-10-31 | $12.41M derived: sum of 4 quarters · filed 2019-10-31 |
| 2019-06-30 | $43.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $26.37M 10-Q · filed 2019-08-06 | $42.50M derived: sum of 3 quarters · filed 2019-08-06 | $51.58M derived: sum of 4 quarters · filed 2019-10-31 |
| 2019-03-31 | -$17.13M 10-Q · filed 2019-05-02 | -$1.00M derived: sum of 2 quarters · filed 2019-05-02 | $8.08M derived: sum of 3 quarters · filed 2019-10-31 | $7.39M derived: sum of 4 quarters · filed 2019-10-31 |
| 2018-12-31 | $16.13M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14 | $25.21M derived: sum of 2 quarters · filed 2019-10-31 | $24.52M derived: sum of 3 quarters · filed 2019-10-31 | $15.48M 10-K · filed 2019-02-14 |
| 2018-09-30 | $9.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $8.39M derived: sum of 2 quarters · filed 2019-10-31 | -$650.00K 10-Q · filed 2019-10-31 | $11.68M derived: sum of 4 quarters · filed 2019-10-31 |
| 2018-06-30 | -$693.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | -$9.73M 10-Q · filed 2019-08-06 | $2.60M derived: sum of 3 quarters · filed 2019-08-06 | -$6.35M derived: sum of 4 quarters · filed 2019-08-06 |
| 2018-03-31 | -$9.04M 10-Q · filed 2019-05-02 | $3.29M derived: sum of 2 quarters · filed 2019-05-02 | -$5.66M derived: sum of 3 quarters · filed 2019-05-02 | -$2.91M derived: sum of 4 quarters · filed 2019-05-02 |
| 2017-12-31 | $12.33M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14 | $3.39M derived: sum of 2 quarters · filed 2019-02-14 | $6.13M derived: sum of 3 quarters · filed 2019-02-14 | -$4.94M 10-K · filed 2019-02-14 |
| 2017-09-30 | -$8.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$6.20M derived: sum of 2 quarters · filed 2018-11-07 | -$17.27M 10-Q · filed 2018-11-07 | -$5.71M derived: sum of 4 quarters · filed 2019-02-14 |
| 2017-06-30 | $2.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | -$8.33M 10-Q · filed 2018-08-02 | $3.23M derived: sum of 3 quarters · filed 2019-02-14 | $5.36M derived: sum of 4 quarters · filed 2019-02-14 |
| 2017-03-31 | -$11.07M 10-Q · filed 2018-05-04 | $493.00K derived: sum of 2 quarters · filed 2019-02-14 | $2.62M derived: sum of 3 quarters · filed 2019-02-14 | -$1.32M derived: sum of 4 quarters · filed 2019-02-14 |
| 2016-12-31 | $11.56M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14 | $13.69M derived: sum of 2 quarters · filed 2019-02-14 | $9.75M derived: sum of 3 quarters · filed 2019-02-14 | $10.10M 10-K · filed 2019-02-14 |
| 2016-09-30 | $2.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$1.81M derived: sum of 2 quarters · filed 2017-11-07 | -$1.46M 10-Q · filed 2017-11-07 | $1.10M derived: sum of 4 quarters · filed 2018-02-15 |
| 2016-06-30 | -$3.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$3.59M 10-Q · filed 2017-08-09 | -$1.03M derived: sum of 3 quarters · filed 2018-02-15 | -$719.00K derived: sum of 4 quarters · filed 2018-02-15 |
| 2016-03-31 | $347.00K 10-Q · filed 2017-05-05 | $2.91M derived: sum of 2 quarters · filed 2018-02-15 | $3.22M derived: sum of 3 quarters · filed 2018-02-15 | $1.27M derived: sum of 4 quarters · filed 2018-02-15 |
| 2015-12-31 | $2.56M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15 | $2.87M derived: sum of 2 quarters · filed 2018-02-15 | $926.00K derived: sum of 3 quarters · filed 2018-02-15 | $1.68M 10-K · filed 2018-02-15 |
| 2015-09-30 | $310.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | -$1.64M derived: sum of 2 quarters · filed 2016-11-03 | -$885.00K 10-Q · filed 2016-11-03 | $8.78M derived: sum of 4 quarters · filed 2017-02-15 |
| 2015-06-30 | -$1.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | -$1.20M 10-Q · filed 2016-08-04 | $8.47M derived: sum of 3 quarters · filed 2017-02-15 | $7.52M derived: sum of 4 quarters · filed 2017-02-15 |
| 2015-03-31 | $750.00K 10-Q · filed 2016-05-04 | $10.42M derived: sum of 2 quarters · filed 2017-02-15 | $9.47M derived: sum of 3 quarters · filed 2017-02-15 | $10.97M derived: sum of 4 quarters · filed 2017-02-15 |
| 2014-12-31 | $9.67M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-15 | $8.72M derived: sum of 2 quarters · filed 2017-02-15 | $10.22M derived: sum of 3 quarters · filed 2017-02-15 | $8.84M 10-K · filed 2017-02-15 |
| 2014-09-30 | -$947.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $553.00K derived: sum of 2 quarters · filed 2015-11-09 | -$826.00K 10-Q · filed 2015-11-09 | $2.34M derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-06-30 | $1.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $121.00K 10-Q · filed 2015-08-07 | $3.29M derived: sum of 3 quarters · filed 2016-02-12 | $1.48M derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-03-31 | -$1.38M 10-Q · filed 2015-05-08 | $1.79M derived: sum of 2 quarters · filed 2016-02-12 | -$17.00K derived: sum of 3 quarters · filed 2016-02-12 | $1.41M derived: sum of 4 quarters · filed 2016-02-12 |
| 2013-12-31 | $3.17M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12 | $1.36M derived: sum of 2 quarters · filed 2016-02-12 | $2.79M derived: sum of 3 quarters · filed 2016-02-12 | $1.83M 10-K · filed 2016-02-12 |
| 2013-09-30 | -$1.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | -$377.00K derived: sum of 2 quarters · filed 2014-11-06 | -$1.34M 10-Q · filed 2014-11-06 | -$2.37M derived: sum of 4 quarters · filed 2015-02-13 |
| 2013-06-30 | $1.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | $470.00K 10-Q · filed 2014-08-08 | -$559.00K derived: sum of 3 quarters · filed 2015-02-13 | -$985.00K derived: sum of 4 quarters · filed 2015-02-13 |
| 2013-03-31 | -$959.00K 10-Q · filed 2014-05-09 | -$1.99M derived: sum of 2 quarters · filed 2015-02-13 | -$2.41M derived: sum of 3 quarters · filed 2015-02-13 | -$1.23M derived: sum of 4 quarters · filed 2015-02-13 |
| 2012-12-31 | -$1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-13 | -$1.46M derived: sum of 2 quarters · filed 2015-02-13 | -$275.00K derived: sum of 3 quarters · filed 2015-02-13 | -$1.74M 10-K · filed 2015-02-13 |
| 2012-09-30 | -$426.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $754.00K derived: sum of 2 quarters · filed 2013-11-07 | -$707.00K 10-Q · filed 2013-11-07 | -$393.00K derived: sum of 4 quarters · filed 2014-02-20 |
| 2012-06-30 | $1.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | -$281.00K 10-Q · filed 2013-08-09 | $33.00K derived: sum of 3 quarters · filed 2014-02-20 | -$2.43M derived: sum of 4 quarters · filed 2014-02-20 |
| 2012-03-31 | -$1.46M 10-Q · filed 2013-05-07 | -$1.15M derived: sum of 2 quarters · filed 2014-02-20 | -$3.61M derived: sum of 3 quarters · filed 2014-02-20 | -$1.46M derived: sum of 4 quarters · filed 2014-02-20 |
| 2011-12-31 | $314.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-20 | -$2.15M derived: sum of 2 quarters · filed 2014-02-20 | $0.00 derived: sum of 3 quarters · filed 2014-02-20 | -$3.51M 10-K · filed 2014-02-20 |
| 2011-09-30 | -$2.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-05 | -$314.00K derived: sum of 2 quarters · filed 2012-11-05 | -$3.83M 10-Q · filed 2012-11-05 | -$1.07M derived: sum of 4 quarters · filed 2013-02-19 |
| 2011-06-30 | $2.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | -$1.36M 10-Q · filed 2012-08-08 | $1.39M derived: sum of 3 quarters · filed 2013-02-19 | -$2.45M derived: sum of 4 quarters · filed 2013-02-19 |
| 2011-03-31 | -$3.51M 10-Q · filed 2012-05-03 | -$761.00K derived: sum of 2 quarters · filed 2013-02-19 | -$4.60M derived: sum of 3 quarters · filed 2013-02-19 | -$1.19M derived: sum of 4 quarters · filed 2013-02-19 |
| 2010-12-31 | $2.75M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-19 | -$1.09M derived: sum of 2 quarters · filed 2013-02-19 | $2.32M derived: sum of 3 quarters · filed 2013-02-19 | -$3.18M 10-K · filed 2013-02-19 |
| 2010-09-30 | -$3.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | -$427.00K derived: sum of 2 quarters · filed 2011-11-03 | -$5.93M 10-Q · filed 2011-11-03 | -$1.86M derived: sum of 4 quarters · filed 2012-02-13 |
| 2010-06-30 | $3.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-03 | -$2.09M 10-Q · filed 2011-08-03 | $1.97M derived: sum of 3 quarters · filed 2012-02-13 | $3.94M derived: sum of 4 quarters · filed 2012-02-13 |
| 2010-03-31 | -$5.50M 10-Q · filed 2011-05-05 | -$1.44M derived: sum of 2 quarters · filed 2012-02-13 | $525.00K derived: sum of 3 quarters · filed 2012-02-13 | |
| 2009-12-31 | $4.06M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-13 | $6.03M derived: sum of 2 quarters · filed 2012-02-13 | $9.90M 10-K · filed 2012-02-13 | |
| 2009-09-30 | $1.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-04 | $5.84M 10-Q · filed 2010-11-04 | ||
| 2009-06-30 | $3.88M 10-Q · filed 2010-08-05 | |||
| 2008-12-31 | -$1.24M 10-K · filed 2011-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |